Expression of EBV-encoded oncogenes and EBV-like virions in multiple canine tumors

Veterinary Microbiology

Volumn 163, Issue 1-2, 2013, Pages 79-89

  Chiu, Hung Chuan ^a   Chow, Kuan Chih ^a   Fan, Yi Hsin ^a   Chang, Shih Chieh ^a   Chiou, Shiow Her ^a   Chiang, Shu Fen ^b   Chiou, Che Hao ^a   Wu, Guo Hua ^a   Yang, Hsiu Ching ^a   Ho, Shu Peng ^a   Chen, Yuh Kun ^a   Lee, Wei Cheng ^a   Sun, H Sunny ^c  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

BamHI H rightward reading frame 1; EBV encoded RNA; Epstein Barr virus; Latent membrane protein 1; Oral melanoma; Viral Bcl 2

Indexed keywords

LATENT MEMBRANE PROTEIN 1;

AMELANOTIC MELANOMA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DNA SEQUENCE; DOG; EPSTEIN BARR VIRUS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MOUTH TUMOR; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRION; VIRUS ONCOGENE;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; DOG DISEASES; DOGS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; ONCOGENES; POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL PROTEINS; VIRION;

CANIS FAMILIARIS; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; ONCOVIRINAE;

EID: 84874578035     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2012.12.022     Document Type: Article

References (39)

1. Ambinder R.F., Mann R.B. Epstein-Barr-encoded RNA in situ hybridization: diagnostic applications. Hum. Pathol. 1994, 25:602-605.
2. Baer R., Bankier A.T., Biggin M.D., Deininger P.L., Farrell P.J., Gibson T.J., Hatfull G., Hudson G.S., Satchwell S.C., Seguin C., Tuffnell P.S., Barrell B.G. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984, 310:207-211.
3. Brouillette J.A., Andrew J.R., Venta P.J. Estimate of nucleotide diversity in dogs with a pool-and-sequence method. Mamm. Genome 2000, 11:1079-1086.
4. Chang K.L., Chen Y.Y., Shibata D., Weiss L.M. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn. Mol. Pathol. 1992, 1:246-255.
5. Chiou S.H., Chow K.C., Yang C.H., Chiang S.F., Lin C.H. Discovery of Epstein-Barr virus (EBV)-encoded RNA signal and EBV nuclear antigen leader protein DNA sequence in pet dogs. J. Gen. Virol. 2005, 86:899-905.
6. Crawford D.H. Biology and disease associations of Epstein-Barr virus. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2001, 356:461-473.
7. Ehlers B., Spiess K., Leendertz F., Peeters M., Boesch C., Gatherer D., McGeoch D.J. Lymphocryptovirus phylogeny and the origins of Epstein-Barr virus. J. Gen. Virol. 2010, 91:630-642.
8. Epstein M.A., Achong B.G., Barr Y.M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964, 1:702-703.
9. Epstein M.A., Rabin H., Ball G., Rickinson A.B., Jarvis J., Melendez L.V. Pilot experiments with EB virus in owl monkeys (Aotus trivirgatus). II. EB virus in a cell line from an animal with reticuloproliferative disease. Int. J. Cancer 1973, 12:319-332.
10. Falk L., Wolfe L., Deinhardt F., Paciga J., Dombos L., Klein G., Henle W., Henle G. Epstein-Barr virus: transformation of non-human primate lymphocytes in vitro. Int. J. Cancer 1974, 13:363-376.
11. Gires O., Kohlhuber F., Kilger E., Baumann M., Kieser A., Kaiser C., Zeidler R., Scheffer B., Ueffing M., Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J. 1999, 18:3064-3073.
12. Graham L., Orenstein J.M. Processing tissue and cells for transmission electron microscopy in diagnostic pathology and research. Nat. Protoc. 2007, 2:2439-2450.
13. Gulley M.L. Molecular diagnosis of Epstein-Barr virus-related diseases. J. Mol. Diagn. 2001, 3:1-10.
14. Huang S.H., Kozak P.J., Kim J., Habineza-Ndikuyeze G., Meade C., Gaurnier-Hausser A., Patel R., Robertson E., Mason N.J. Evidence of an oncogenic gammaherpesvirus in domestic dogs. Virology 2012, 427:107-117.
15. Huen D.S., Henderson S.A., Croom-Carter D., Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 1995, 10:549-560.
16. Jang H.S., Cho J.O., Yoon C.Y., Kim H.J., Park J.C. Demonstration of Epstein-Barr virus in odontogenic and nonodontogenic tumors by the polymerase chain reaction (PCR). J. Oral Pathol. Med. 2001, 30:603-610.
17. Johnson D.C., Baines J.D. Herpesviruses remodel host membranes for virus egress. Nat. Rev. Microbiol. 2011, 9:382-394.
18. Kaye K.M., Izumi K.M., Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:9150-9154.
19. Khanim F., Dawson C., Meseda C.A., Dawson J., Mackett M., Young L.S. BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates. J. Gen. Virol. 1997, 78:2987-2999.
20. Kieser A. Signal transduction by the Epstein-Barr virus oncogene latent membrane protein 1 (LMP1). Signal Transduct. 2007, 7:20-33.
21. Lo A.K.F., To K.F., Lo K.W., Lung R.W.M., Hui J.W.Y., Liao G., Hayward S.D. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:16164-16169.
22. Macsween K.F., Crawford D.H. Epstein-Barr virus-recent advances. Lancet Infect. Dis. 2003, 3:131-140.
23. Miller G., Shope T., Coope D., Waters L., Pagano J., Bornkamn G., Henle W. Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses. J. Exp. Med. 1977, 145:948-967.
24. Milman G., Smith K.C., Erles K. Serological detection of Epstein-Barr virus infection in dogs and cats. Vet. Microbiol. 2011, 150:15-20.
25. Oudejans J.J., van den Brule A.J., Jiwa N.M., de Bruin P.C., Ossenkoppele G.J., van der Valk P., Walboomers J.M., Meijer C.J. BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes. Blood 1995, 86:1893-1902.
26. Pallesen G., Hamilton-Dutoit S.J., Zhou X. The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: two new developments in the EBV field. Adv. Cancer Res. 1993, 62:179-239.
27. Ponte P., Gunning P., Blau H., Kedes L. Human actin genes are single copy for alpha-skeletal and alpha-cardiac actin but multicopy for beta- and gamma-cytoskeletal genes: 3' untranslated regions are isotype specific but are conserved in evolution. Mol. Cell. Biol. 1983, 3:1783-1791.
28. Ryan J.L., Morgan D.R., Dominguez R.L., Thorne L.B., Elmore S.H., Mino-Kenudson M., Lauwers G.Y., Booker J.K., Gulley M.L. High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma. Lab. Invest. 2009, 89:80-90.
29. Schulze C., Baumgärtner W. Nested polymerase chain reaction and in situ hybridization for diagnosis of canine herpesvirus infection in puppies. Vet. Pathol. 1998, 35:209-217.
30. Shinokuma A., Hirakawa N., Tamiya S., Oda Y., Komiyama S., Tsuneyoshi M. Evaluation of Epstein-Barr virus infection in sinonasal small round cell tumors. J. Cancer Res. Clin. Oncol. 2000, 126:12-18.
31. Shope T., Dechairo D., Miller G. Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proc. Natl. Acad. Sci. U.S.A. 1973, 70:2487-2491.
32. Taheri-Kadkhoda Z., Magnusson B., Svensson M., Mercke C., Bjork-Eriksson T. Expression modes and clinical manifestations of latent membrane protein 1, Ki-67, cyclin-B1, and epidermal growth factor receptor in nonendemic nasopharyngeal carcinoma. Head Neck 2009, 31:482-492.
33. Tierney R.J., Kao K.Y., Nagra J.K., Rickinson A.B. Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains. J. Virol. 2011, 85:12362-12375.
34. Vaysberg M., Hatton O., Lambert S.L., Snow A.L., Wong B., Krams S.M., Martinez O.M. Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos. J. Biol. Chem. 2008, 283:36573-36585.
35. Vazirabadi G., Geiger T.R., Coffin W.F., Martin J.M. Epstein-Barr virus latent membrane protein-1 (LMP-1) and lytic LMP-1 localization in plasma membrane-derived extracellular vesicles and intracellular virions. J. Gen. Virol. 2003, 84:1997-2008.
36. Wagner H.J., Bein G., Bitsch A., Kirchner H. Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction. J. Clin. Microbiol. 1992, 30:2826-2829.
37. Wang W.H., Chang L.K., Liu S.T. Molecular interactions of Epstein-Barr virus capsid proteins. J. Virol. 2011, 85:1615-1624.
38. Watanabe A., Maruo S., Ito T., Ito M., Katsumura K.R., Takada K. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1. J. Virol. 2010, 84:2893-2901.
39. Zuercher E., Butticaz C., Wyniger J., Martinez R., Battegay M., Boffi El Amari E., Dang T., Egger J.F., Fehr J., Mueller-Garamvögyi E., Parini A., Schaefer S.C., Schoeni-Affolter F., Thurnheer C., Tinguely M., Telenti A., Rothenberger S. Genetic diversity of EBV-encoded LMP1 in the Swiss HIV cohort study and implication for NF-Kb activation. PLoS ONE 2012, 7:e32168. Swiss HIV Cohort Study.